TY - JOUR
T1 - Gender differences in the clinical characteristics and outcomes of patients with vasospastic angina
T2 - A report from the Japanese coronary spasm association
AU - Kawana, Akiko
AU - Takahashi, Jun
AU - Takagi, Yusuke
AU - Yasuda, Satoshi
AU - Sakata, Yasuhiko
AU - Tsunoda, Ryusuke
AU - Ogata, Yasuhiro
AU - Seki, Atsushi
AU - Sumiyoshi, Tetsuya
AU - Matsui, Motoyuki
AU - Goto, Toshikazu
AU - Tanabe, Yasuhiko
AU - Sueda, Shozo
AU - Kubo, Norifumi
AU - Momomura, Shin Ichi
AU - Ogawa, Hisao
AU - Shimokawa, Hiroaki
PY - 2013
Y1 - 2013
N2 - Background: Accumulating evidence has demonstrated the gender differences in the clinical characteristics and outcomes of patients with ischemic heart disease. However, it remains to be elucidated whether it is also the case for vasospastic angina (VSA). Methods and Results: We enrolled a total of 1,429 VSA patients (male/female, 1090/339; median age 66 years) in our nationwide multicenter registry by the Japanese Coronary Spasm Association. As compared with male patients, female patients were characterized by older age (median 69 vs. 66 years), lower incidence of smoking (20% vs. 72%) and less significant organic stenosis (9% vs. 16%) (all P=0.001). Multivariate analysis demonstrated that the predictors of major adverse cardiac events (MACE) were considerably different by genders; women were more associated with age and electrical abnormalities, whereas men with structural abnormalities. Overall 5-year MACE-free survival was comparable between both genders. However, when the patients were divided into 3 groups by age [young (<50 years), middle-aged (50-64 years) and elderly (≥65 years)], the survival was significantly lower in the young female group (young 82%, middle-aged 92%, elderly 96%, P<0.01), where a significant interaction was noted between age and smoking. In contrast, the survival was comparable among the 3 age groups of male patients. Conclusions: These results indicate that there are gender differences in the characteristics and outcomes of VSA patients, suggesting the importance of gender-specific management of the disorder.
AB - Background: Accumulating evidence has demonstrated the gender differences in the clinical characteristics and outcomes of patients with ischemic heart disease. However, it remains to be elucidated whether it is also the case for vasospastic angina (VSA). Methods and Results: We enrolled a total of 1,429 VSA patients (male/female, 1090/339; median age 66 years) in our nationwide multicenter registry by the Japanese Coronary Spasm Association. As compared with male patients, female patients were characterized by older age (median 69 vs. 66 years), lower incidence of smoking (20% vs. 72%) and less significant organic stenosis (9% vs. 16%) (all P=0.001). Multivariate analysis demonstrated that the predictors of major adverse cardiac events (MACE) were considerably different by genders; women were more associated with age and electrical abnormalities, whereas men with structural abnormalities. Overall 5-year MACE-free survival was comparable between both genders. However, when the patients were divided into 3 groups by age [young (<50 years), middle-aged (50-64 years) and elderly (≥65 years)], the survival was significantly lower in the young female group (young 82%, middle-aged 92%, elderly 96%, P<0.01), where a significant interaction was noted between age and smoking. In contrast, the survival was comparable among the 3 age groups of male patients. Conclusions: These results indicate that there are gender differences in the characteristics and outcomes of VSA patients, suggesting the importance of gender-specific management of the disorder.
KW - Gender difference
KW - Prognosis
KW - Vasospastic angina
UR - http://www.scopus.com/inward/record.url?scp=84876763936&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84876763936&partnerID=8YFLogxK
U2 - 10.1253/circj.CJ-12-1486
DO - 10.1253/circj.CJ-12-1486
M3 - Article
C2 - 23363662
AN - SCOPUS:84876763936
SN - 1346-9843
VL - 77
SP - 1267
EP - 1274
JO - Circulation Journal
JF - Circulation Journal
IS - 5
ER -